OAO 2021 Virtual PGC Series Course Evaluation
RequiredRequired Question(s)
Progress: 
 
Required
Please provide your legal First and Last Name with Certification (e.g. John Q. Smith, MD). This information will only be used for accreditation purposes.

First Name:
Last Name:
Email Address:
emailaddress@xyz.com
License (MD, DO, etc.):

Required

Was this activity free of commercial bias?

YES
NO (if you choose NO, please explain below)
  • Comment:

  • 500 characters left.
PLEASE EVALUATE EACH COURSE:
 
Required
Strategies for Complex Cataract Surgery (2 Videos) | David F. Chang, MD
Learning ObjectivesRecognize and characterize the wide spectrum of zonulopathy and employ appropriate strategies based on this recognition, understand the risk factors for IFIS and better understand the prevention and management of IFIS during cataract surgery, and understand techniques to reduce morbidity associated with phaco in rock hard cataracts and the associated co-morbidities, such as zonulopathy, small pupils, poor red reflex, and crowded anterior segment.

Did this presentation meet the learning objectives?
YES
NO
Did not attend
Strategies for Complex Cataract Surgery (2 Videos) | David F. Chang, MD

What changes do you anticipate in patient care in your practice as a result of this course?
 

350 characters left.
Strategies for Complex Cataract Surgery (2 Videos) | David F. Chang, MD

Additional comments:
 

350 characters left.
Required
Update on Refractive IOLs for Cataract Surgery | David F. Chang, MD
Learning ObjectivesUnderstand methods to prevent and manage toric IOL misalignment, improved ability to communicate the differences between different advanced technology refractive IOLs to patients, and understand the practical aspects of adopting adjustable IOL technology.

Did this presentation meet the learning objectives?
YES
NO
Did not attend
Update on Refractive IOLs for Cataract Surgery | David F. Chang, MD

What changes do you anticipate in patient care in your practice as a result of this course?
 

350 characters left.
Update on Refractive IOLs for Cataract Surgery | David F. Chang, MD

Additional comments:
 

350 characters left.
Required
Lessons Learned from the Greatest Team of Cataract Surgeons | David F. Chang, MD
Learning ObjectivesUnderstand the evidence supporting routine intracameral moxifloxacin prophylaxis for cataract surgery, understand the extent of O.R. waste due to mandated single use of drugs and supplies for cataract surgery, and understand the relative pros and cons for manual ECCE in dealing with mature cataracts, particularly for less experienced surgeons.

Did this presentation meet the learning objectives?
YES
NO
Did not attend

Lessons Learned from the Greatest Team of Cataract Surgeons | David F. Chang, MD


What changes do you anticipate in patient care in your practice as a result of this course?

 

350 characters left.

Lessons Learned from the Greatest Team of Cataract Surgeons | David F. Chang, MD


Additional Comments:

 

350 characters left.
Required
Ocular Manifestations of Systemic Autoimmune Diseases | Quan Dong Nguyen, MD
Learning ObjectivesRecognize that ocular manifestations are not uncommon in selected systemic autoimmune diseases, understand that ocular manifestations may be the very initial signs of previously undiagnosed underlying systemic diseases, and comprehend that the management of ocular diseases in patients with underlying systemic diseases often require systemic therapy or combination of ocular and systemic therapy to provide complete control of the ocular diseases. 

Did this presentation meet the learning objectives?
YES
NO
Did not attend
Ocular Manifestations of Systemic Autoimmune Diseases | Quan Dong Nguyen, MD

What changes do you anticipate in patient care in your practice as a result of this course?
 

350 characters left.
Ocular Manifestations of Systemic Autoimmune Diseases | Quan Dong Nguyen, MD

Additional Comments:
 

350 characters left.
Required
Masquerade Syndrome: Intraocular Lymphoma and Others | Quan Dong Nguyen, MD
Learning Objectives: Recognize the clinical manifestations of intraocular lymphoma, understand that early diagnosis and vigorous therapy, can result in better outcomes, and comprehend that early diagnosis depends upon ophthalmologist suspicion of the diagnosis, early diagnostic procedure, and proper handling and analysis of the specimen.
 
Did this presentation meet the learning objectives? 
YES
NO
Did not attend
Masquerade Syndrome: Intraocular Lymphoma and Others | Quan Dong Nguyen, MD

What changes do you anticipate in patient care in your practice as a result of this course?
 

350 characters left.
Masquerade Syndrome: Intraocular Lymphoma and Others | Quan Dong Nguyen, MD

Additional comments:
 

350 characters left.
Required
Current Concepts in the Diagnosis & Management of Scleritis | Quan Dong Nguyen, MD
Learning Objectives:  Distinguish the various types of scleritis, initiate the suitable evaluations for patients who have scleritis, and recognize the importance of proper therapy, including immunomodulatory therapy, for
scleritis.

Did this presentation meet the learning objectives? 
YES
NO
Did not attend
Current Concepts in the Diagnosis & Management of Scleritis | Quan Dong Nguyen, MD

What changes do you anticipate in patient care in your practice as a result of this course?
 

350 characters left.
Current Concepts in the Diagnosis & Management of Scleritis | Quan Dong Nguyen, MD

Additional Comments:
 

350 characters left.
Required
Top Five Commonly Made Mistakes in Managing Non-Infectious Uveitis | Quan Dong Nguyen, MD
Learning ObjectivesDiscuss the various common errors that can occur for physicians who manage patients with uveitis, emphasize the importance of careful assessment of uveitis patients to enable proper
diagnosis to be made, and provide guidelines in generating appropriate management plans for complex uveitis
patients.

Did this presentation meet the learning objectives? 
YES
NO
Did not attend
Top Five Commonly Made Mistakes in Managing Non-Infectious Uveitis | Quan Dong Nguyen, MD

What changes do you anticipate in patient care in your practice as a result of this course?
 

350 characters left.
Top Five Commonly Made Mistakes in Managing Non-Infectious Uveitis | Quan Dong Nguyen, MD

Additional Comments:
 

350 characters left.
Required
Non-Proliferative Diabetic Retinopathy: Should We Treat? | Diana V. Do, MD
Learning ObjectivesDiscuss the evidence for the use of anti-VEGF agents for NPDR, review the safety of anti-VEGF agents in NPDR, and describe how anti-VEGF agents decrease vision threatening complications.

Did this presentation meet the learning objectives? 
YES
NO
Did not attend
Non-Proliferative Diabetic Retinopathy: Should We Treat? | Diana V. Do, MD

What changes do you anticipate in patient care in your practice as a result of this course?
 

350 characters left.
Non-Proliferative Diabetic Retinopathy: Should We Treat? | Diana V. Do, MD

Additional Comments:
 

350 characters left.
Required
Safety of Intravitreal Anti-VEGF Agents - Should We Be Concerned? | Diana V. Do, MD
Learning ObjectivesReview safety of commonly used intravitreal anti-VEGF agents including ranibizumab,
aflibercept and bevacizumab, discuss the recent safety events associated with brolucizmab and understand how to assess for IOI and retinal vasculitis.

Did this presentation meet the learning objectives? 
YES
NO
Did not attend
Safety of Intravitreal Anti-VEGF Agents - Should We Be Concerned? | Diana V. Do, MD

What changes do you anticipate in patient care in your practice as a result of this course?
 

350 characters left.
Safety of Intravitreal Anti-VEGF Agents - Should We Be Concerned? | Diana V. Do, MD

Additional Comments:
 

350 characters left.
Required
Which Anti-VEGF Regimen is Best for Your Wet Age-Related Macular Degeneration Patients? | Diana V. Do, MD
Learning ObjectivesReview the clinical trial evidence for fixed dosing, as-needed dosing and treat and extend
dosing, discuss visual acuity outcomes at month 12 and 24 with anti-VEGF dosing regimens, and nderstand strategies to improve and maintain vision in wet AMD patients.

Did this presentation meet the learning objectives? 
YES
NO
Did not attend
Which Anti-VEGF Regimen is Best for Your Wet Age-Related Macular Degeneration Patients? | Diana V. Do, MD

What changes do you anticipate in patient care in your practice as a result of this course?
 

350 characters left.
Which Anti-VEGF Regimen is Best for Your Wet Age-Related Macular Degeneration Patients? | Diana V. Do, MD

Additional Comments:
 

350 characters left.
Required
How Will We Treat Wet AMD in 2023? | Diana V. Do, MD
Learning ObjectivesReview the current biologics in late stage development for wet AMD, discuss the efficacy and safety of these new biologics, and discuss the dosing regimens for new biologics in evidence.

Did this presentation meet the learning objectives? 
YES
NO
Did not attend
How Will We Treat Wet AMD in 2023? | Diana V. Do, MD

What changes do you anticipate in patient care in your practice as a result of this course?
 

350 characters left.
How Will We Treat Wet AMD in 2023? | Diana V. Do, MD

Additional Comments:
 

350 characters left.
Required
Neuro-Ophthalmic Complications of COVID-19 | Mark Dinkin, MD
Learning ObjectivesUnderstand the various types of vision loss associated with COVID-19, including cortical
stroke, optic neuritis and papilledema, understand the syndromes affecting eye movements associated with COVID-19 including cranial nerve palsy, Miller Fisher syndrome, myasthenia gravis and brainstem encephalitis, and understand the theoretical mechanisms by which COVID-19 may lead to neuro-ophthalmic
dysfunction, including endothelial dysfunction, hypercoagulability, para-infectious inflammation and direct neurotropism.

Did this presentation meet the learning objectives? 
YES
NO
Did not attend
Neuro-Ophthalmic Complications of COVID-19 | Mark Dinkin, MD

What changes do you anticipate in patient care in your practice as a result of this course?
 

350 characters left.
Neuro-Ophthalmic Complications of COVID-19 | Mark Dinkin, MD

Additional Comments:
 

350 characters left.
Required
Venous Sinus Stenosis in Idiopathic Intracranial Hypertension and the Role for Venous
Stenting | Mark Dinkin, MD
Learning ObjectivesUnderstand the data arguing for and against a role of venous sinus stenosis in the
pathophysiology of IIH, describe the outcomes for patients undergoing venous stenting for IIH, including effect on symptoms, visual field loss, disc edema and retinal nerve fiber layer thickness, and enumerate the range of complications that have been associated with stenting for IIH and understand the frequency and likely etiology of secondary stent failure.

Did this presentation meet the learning objectives? 
YES
NO
Did not attend
Venous Sinus Stenosis in Idiopathic Intracranial Hypertension and the Role for Venous
Stenting | Mark Dinkin, MD

What changes do you anticipate in patient care in your practice as a result of this course?
 

350 characters left.
Venous Sinus Stenosis in Idiopathic Intracranial Hypertension and the Role for Venous
Stenting | Mark Dinkin, MD

Additional Comments:
 

350 characters left.
Required
Higher Order Cortical Visual Syndromes | Mark Dinkin, MD
Learning ObjectivesDescribe the organization of the post-striate visual processing pathways into the dorsal and ventral pathways and understand the basic anatomy of both, enumerate several examples of ventral pathway dysfunction and describe the typical patient presentation for each, and enumerate several examples of dorsal pathway dysfunction and describe the typical patient presentation for each.

Did this presentation meet the learning objectives? 
YES
NO
Did not attend
Higher Order Cortical Visual Syndromes | Mark Dinkin, MD

What changes do you anticipate in patient care in your practice as a result of this course?
 

350 characters left.
Higher Order Cortical Visual Syndromes | Mark Dinkin, MD

Additional Comments:
 

350 characters left.
Required
Did the program achieve its primary objectives to increase competence, (ability to apply knowledge, skills, and judgment in practice)?
 YES NO    
Better understand the prevention and management of IFIS during cataract surgery    
Understand the evidence supporting routine intracameral moxifloxacin prophylaxis for cataract surgery    
Understand the various types of vision loss associated with COVID-19, including cortical stroke, optic neuritis and papilledema    
Understand the data arguing for and against a role of venous sinus stenosis in the pathophysiology of IIH    
Describe the organization of the post-striate visual processing pathways into the dorsal and ventral pathways and understand the basic anatomy of both    
Understanding the latest clinical trial data to review the benefits and risks of anti-VEGF therapy for NPDR    
Learned to recognize the clinical manifestations of intraocular lymphoma    
Increased ability to diagnose and manage non-infectious uveitis    
Ability to recognize ocular signs of underlying systemic autoimmune diseases    
Required
As a result of participating in this activity, the primary changes I will make in my practice are:
 

350 characters left.
Required
Please rate our speakers for their content and presentation skills: 1=Poor and 5=Excellent. Please add additional comments.
 
David F. Chang, MD | Cataract
Quan Dong Nguyen, MD | Uveitis
Diana V. Do, MD | Retina
Marc Dinkin, MD | Neuro-Ophthalmology
  • Comment:

  • 500 characters left.
Required
What practice areas could you use additional training in to practice more effectively? Please be specific:
 

350 characters left.
Required
How did this activity enhance your knowledge or skills, or address your patient care practice gaps? Please be specific:
 

350 characters left.